BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12679441)

  • 1. A method for identification of the peptides that bind to a clone of thyroid-stimulating antibodies in the serum of Graves' disease patients.
    Na CH; Lee MH; Cho BY; Chae CB
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1570-6. PubMed ID: 12679441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
    Park JY; Kim IJ; Lee MH; Seo JK; Suh PG; Cho BY; Ryu SH; Chae CB
    Endocrinology; 1997 Feb; 138(2):617-26. PubMed ID: 9002995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the peptides that inhibit the function of human monoclonal thyroid-stimulating antibodies from phage-displayed peptide library.
    Byun CH; Park JY; Akamizu T; Chae CB
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3311-8. PubMed ID: 11443206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin G that interferes with thyroid-stimulating antibody measurements can be eliminated specifically by incubation with synthetic peptides corresponding to partial sequences of the human thyrotropin receptor.
    Ueda Y; Sugawa H; Akamizu T; Okuda J; Kiho Y; Mori T
    Thyroid; 1993; 3(2):111-7. PubMed ID: 8103692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y; Kajita Y; Hamazu M; Nagata A
    Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic oligopeptide derived from human thyrotropin receptor sequence binds to Graves' immunoglobulin and inhibits thyroid stimulating antibody activity but lacks interactions with TSH.
    Mori T; Sugawa H; Piraphatdist T; Inoue D; Enomoto T; Imura H
    Biochem Biophys Res Commun; 1991 Jul; 178(1):165-72. PubMed ID: 1676885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
    Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
    Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
    J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of N-terminal region of the thyrotropin (TSH) receptor in signal transduction for TSH or thyroid stimulating antibody.
    Ohmori M; Endo T; Ikeda M; Onaya T
    Biochem Biophys Res Commun; 1991 Jul; 178(2):733-8. PubMed ID: 1677567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of an scFv antibody fragment that binds to immunoglobulin G of Graves' disease patients and inhibits autoantibody-mediated thyroid-stimulating activity.
    Zhao Y; Wang SL; Li Q; Ye J; Chen KM; Tian EJ; Chen ZP
    Hybridoma (Larchmt); 2008 Dec; 27(6):445-51. PubMed ID: 19108617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of thyroid-stimulating antibody-stimulated cyclic adenosine monophosphate response by polyethylene glycol, polyvinyl alcohol, and dextran; highly sensitive porcine thyroid cell thyroid-stimulating antibody assay.
    Yamashiro K; Takasu N; Kouki T; Inui T; Ochi Y; Kajita Y; Sato Y; Nagata A
    Thyroid; 1999 Mar; 9(3):263-71. PubMed ID: 10211603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.